Dergiler / Ahi Evran Tıp Dergisi / 2022 / Cilt: 6 - Sayı: 3

Parkinson Hastalığında D Vitamini Düzeyinin Hastalık Şiddeti, Denge ve Düşme ile İlişkisi

The Relationship of Vitamin D Levels with Disease Severity, Balance, and Falls in Parkinson’s Disease

Sayfa
255–260
Yayın Tarihi
2022-12-25
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Amaç: Parkinson hastalığında serum D vitamini düzeyleri ile hastalık şiddeti, denge sorunları ve düşme ve düşme korkusu arasındaki ilişkiyi değerlendirmek.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Amaç: Parkinson hastalığında serum D vitamini düzeyleri ile hastalık şiddeti, denge sorunları ve düşme ve düşme korkusu arasındaki ilişkiyi değerlendirmek.
📊
Temel Bulgular & Veri:Amaç: Parkinson hastalığında serum D vitamini düzeyleri ile hastalık şiddeti, denge sorunları ve düşme ve düşme korkusu arasındaki ilişkiyi değerlendirmek.
💡
Sonuç & Katkı:Amaç: Parkinson hastalığında serum D vitamini düzeyleri ile hastalık şiddeti, denge sorunları ve düşme ve düşme korkusu arasındaki ilişkiyi değerlendirmek.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:düşme korkusu · nörodejenerasyon · postural instability

Özet

Amaç: Parkinson hastalığında serum D vitamini düzeyleri ile hastalık şiddeti, denge sorunları ve düşme ve düşme korkusu arasındaki ilişkiyi değerlendirmek.

Abstract

Purpose: To evaluate the relationship between serum vitamin D levels with disease severity, balance problems and fear of falling in Parkinson’s disease.Materials and Methods: This was a retrospective, cross-sectional study. Participants with Parkinson’s disease and healthy controls aged 45-80 years were included in the study. The outcomes of the study were serum 25(OH) vitamin D levels, Hoehn&Yahr Scale, Unified Parkinson’s Disease Rating Scale-III, Berg balance scale, Tinetti test, and International Falls Efficacy Scale scores.Results: Seventy-two participants with Parkinson’s disease and sixty healthy controls were included in the study. The mean 25(OH) vitamin D level was 17.8±8.2 ng/ml in the PD group, while it was 22.2±9.7 ng/ml in the control group. There was a statistically significant difference in terms of 25(OH) vitamin D levels between the groups (p=0.005). The participants in the PD group were divided into two groups according to the HY scale scores (Early-stage group: Stage 1-2; Advanced-Stage group: Stage 3-4). The mean 25(OH) vitamin D level was 18.6±7.8 ng/ml in the early-stage group, it was 16.5±8.8 ng/ml in the advanced-stage group. No statistically significant differences were identified in both groups (p=0.299). There was no correlation between 25(OH) vitamin D levels, HY stages, BBS, TT, FES-I, and UPDRS-III in PD group (p>0.05).Conclusion: Vitamin D levels were lower in PD than that in healthy controls. However, no significant relationship was found between vitamin D levels and disease severity, balance problem, and fear of falling in PD.

🔖

Bu Makaleye Atıf Yap

KORKMAZ, M. D. (2022). Parkinson Hastalığında D Vitamini Düzeyinin Hastalık Şiddeti, Denge ve Düşme ile İlişkisi. Ahi Evran Tıp Dergisi, Cilt: 6 - Sayı: 3, 255–260. https://ajindex.com/articles/866783

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Peterson AL. A review of vitamin D and Parkinson's disease. Maturitas. 2014;78(1):40-44
  2. Fullard ME, Duda JE. A Review of the Relationship Between Vitamin D and Parkinson Disease Symptoms. Front Neurol. 2020;11:454
  3. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30
  4. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab. 2002;13(3):100-105
  5. Wion D, MacGrogan D, Neveu I, Jehan F, Houlgatte R, Brachet P. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res. 1991;28(1):110-114
  6. Shirazi HA, Rasouli J, Ciric B, Rostami A, Zhang GX. 1,25-Dihydroxyvitamin D3 enhances neural stem cell proliferation and oligodendrocyte differentiation. Exp Mol Pathol. 2015;98(2):240-245
  7. Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EM. Systematic Review of the Relationship between Vitamin D and Parkinson's Disease. J Parkinsons Dis. 2016;6(1):29-37
  8. Lv Z, Qi H, Wang L, et al. Vitamin D status and Parkinson's disease: a systematic review and meta-analysis. Neurol Sci. 2014;35(11):1723-1730
  9. Larsson SC, Singleton AB, Nalls MA, Richards JB. No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study. Mov Disord. 2017;32(8):1249-1252
  10. Peterson AL, Mancini M, Horak FB. The relationship between balance control and vitamin D in Parkinson's disease-a pilot study. Mov Disord. 2013;28(8):1133-1137
  11. Pfeifer M, Begerow B, Minne HW, Suppan K, Fahrleitner-Pammer A, Dobnig H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos Int. 2009;20(2):315-322
  12. Sahin Alak ZY, Ates Bulut E, Dokuzlar O, Yavuz I, Soysal P, Isik AT. Long-term effects of vitamin D deficiency on gait and balance in the older adults. Clin Nutr. 2020;39(12):3756-3762
  13. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19(9):1020-1028
  14. Goetz CG, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord. 2007;22(1):41-47
  15. The Unified Parkin